DMK
VRCA icon

David M. Knott’s Verrica Pharmaceuticals VRCA Stock Holding History

David M. Knott’s Portfolio VRCA Stock Details VRCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-138
Closed -$16K – 157
2021
Q2 		$16K Sell
138
-7,704
-98% -$933K 0.01% 137
2021
Q1 		$1.19M Buy
7,842
+183
+2% +$25.3K 0.51% 46
2020
Q4 		$881K Buy
7,659
+3,046
+66% +$280K 0.4% 45
2020
Q3 		$357K Buy
4,613
+3,118
+209% +$255K 0.21% 59
2020
Q2 		$165K Buy
1,495
+20
+1% +$2.31K 0.09% 63
2020
Q1 		$161K Buy
1,475
+454
+44% +$59.7K 0.1% 75
2019
Q4 		$162K Hold
1,021
– – 0.07% 83
2019
Q3 		$151K Sell
1,021
-90
-8% -$10K 0.06% 83
2019
Q2 		$129K Buy
+1,111
New +$104K 0.05% 84

Other funds holding VRCA

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
KCM
Kornitzer Capital Management Shawnee Mission, Kansas $4.65B AUM 23.83% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FI
Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return
ACM
Altium Capital Management New York $42M AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

David M. Knott's VRCA Position: Q3 2021 in Review

David M. Knott sold out of Verrica Pharmaceuticals (VRCA) in Q3 2021, closing a stake of 138 shares — an estimated $16K sold.

David M. Knott first reported a position in VRCA in Q2 2019 and held it in 9 quarters. The position peaked at $1.19M in Q1 2021. 49 funds tracked by Wall St. Rank hold VRCA as of Q3 2021.

  • David M. Knott reported no remaining Verrica Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • David M. Knott sold 138 Verrica Pharmaceuticals shares in Q3 2021, an estimated $16K.
  • David M. Knott first reported a position in Verrica Pharmaceuticals in Q2 2019 and held it in 9 quarters.
  • David M. Knott's Verrica Pharmaceuticals position peaked at $1.19M in Q1 2021.
  • 49 funds tracked by Wall St. Rank held Verrica Pharmaceuticals as of Q3 2021.

Based on David M. Knott's 13F filing for Q3 2021, filed 12 Nov 2021.